Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_assertion type Assertion NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_head.
- NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_provenance.
- NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_assertion evidence source_evidence_literature NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_provenance.
- NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_assertion SIO_000772 17607666 NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_provenance.
- NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_assertion wasDerivedFrom befree-20150227 NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_provenance.
- NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_assertion wasGeneratedBy ECO_0000203 NP400593.RA3HZFXY41jB2nAjTq2lty36UJQtF9LeAJf2dCczDJLpc130_provenance.